Abstract
Rapid developments in protein engineering, immunology and pharmaceutical research have led to immense demands for synthetic polypeptides. Several polypeptides synthesizing strategies are now available, among which solid-phase synthesis and solution- phase synthesis are especially relevant. This review pretended to compare these two synthesizing strategies with no bias, appreciate their advantages, drawbacks and limitations, and forecast their developmental trends. It also introduced several other special synthetic strategies, and their applications were presented in detail.
Keywords: Peptide, oligopeptide, synthetic peptide, solid phase synthesis, solution phase synthesis, microwave-assisted.
Graphical Abstract
Current Organic Chemistry
Title:Current Status and Future Developments in Synthetic Peptides
Volume: 22 Issue: 20
Author(s): Bing Yu, Ankang Zhang, Min Zhang, Wenli Wang, Wenlong Li, Youqing Shen and Hailin Cong*
Affiliation:
- Institute of Biomedical Materials and Engineering, College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Qingdao University, Qingdao 266071,China
Keywords: Peptide, oligopeptide, synthetic peptide, solid phase synthesis, solution phase synthesis, microwave-assisted.
Abstract: Rapid developments in protein engineering, immunology and pharmaceutical research have led to immense demands for synthetic polypeptides. Several polypeptides synthesizing strategies are now available, among which solid-phase synthesis and solution- phase synthesis are especially relevant. This review pretended to compare these two synthesizing strategies with no bias, appreciate their advantages, drawbacks and limitations, and forecast their developmental trends. It also introduced several other special synthetic strategies, and their applications were presented in detail.
Export Options
About this article
Cite this article as:
Yu Bing , Zhang Ankang , Zhang Min , Wang Wenli , Li Wenlong , Shen Youqing and Cong Hailin *, Current Status and Future Developments in Synthetic Peptides, Current Organic Chemistry 2018; 22 (20) . https://dx.doi.org/10.2174/1385272822666181009151945
DOI https://dx.doi.org/10.2174/1385272822666181009151945 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Free Fatty Acid Receptors as New Potential Targets in Colorectal Cancer
Current Drug Targets Circulating Tumor Cells in Cancer Therapy: Are we off Target?
Current Cancer Drug Targets Ring Finger Ubiquitin Protein Ligases and Their Implication to the Pathogenesis of Human Diseases
Current Pharmaceutical Design STAT-1 and STAT-3: Closely Related Transcription Factors with Antagonistic Effects on Cell Proliferation and Apoptosis
Current Genomics Apoptotic Potency of Angiostatic Compounds in the Treatment of Cancer
Current Pharmaceutical Biotechnology Editorial (Hot Topic: Biomarkers of Oxidative Stress and Cancer: From Chemistry, Biology to Clinical Applications and Personalized Therapy)
Current Molecular Medicine Trends in Biotechnological Drugs for Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Inhibition of Proliferation and Induction of Apoptosis by Thymoquinone via Modulation of TGF Family, p53, p21 and Bcl-2α in Leukemic Cells
Anti-Cancer Agents in Medicinal Chemistry Modulation of Stem Cell Differentiation by the Influence of Nanobiomaterials/ Carriers
Current Stem Cell Research & Therapy Therapeutic Targeting of Cancers with Loss of PTEN Function
Current Drug Targets Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8
Anti-Cancer Agents in Medicinal Chemistry Experimental Models of Relapsing-Remitting Multiple Sclerosis: Current Concepts and Perspective
Current Neurovascular Research Atypical GTPases as Drug Targets
Anti-Cancer Agents in Medicinal Chemistry Editorial [Hot Topic: The Current World Health Organization Classification of the Myeloproliferative and Myelodysplastic/myeloproliferative Neoplasms and Correlation with Pertinent Targeted Therapy (Guest Editor: Cherie H. Dunphy)]
Current Cancer Therapy Reviews Modelling Human Disease with Pluripotent Stem Cells
Current Gene Therapy Inhibition of the ATPase Domain of Human Topoisomerase IIa on HepG2 Cells by 1, 2-benzenedicarboxylic Acid, Mono (2-ethylhexyl) Ester: Molecular Docking and Dynamics Simulations
Current Cancer Drug Targets Genetic Polymorphisms in the Growth Hormone Receptor: Impact on Growth Response and Disease Susceptibility
Current Pharmacogenomics and Personalized Medicine Recent Patents on Genes and Gene Sequences Useful for Developing Breast Cancer Detection Systems
Recent Patents on DNA & Gene Sequences Trans-Resveratrol: A Magical Elixir of Eternal Youth?
Current Medicinal Chemistry Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities
Current Medicinal Chemistry